Irma Convertino

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Venues

Expert opinion on drug discovery

Pharmaceuticals (Basel, Switzerland)

Journal of clinical medicine

British journal of clinical pharmacology

University of Pisa

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pisa

Italy

PhD student :: Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine

Universita' di Pisa Nov 01 2018 - Nov 01 2021

Italy

Dottorandi :: DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA

Publications

Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Marco Tuccori
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence. Expert opinion on drug discovery 18 (3) (2023)
Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Marco Tuccori
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence. Expert opinion on drug discovery 18 (3) (2023)
Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Marco Tuccori
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence. Expert opinion on drug discovery 18 (3) (2023)
Irma Convertino, Valentina Lorenzoni, Rosa Gini, Giuseppe Turchetti, Elisabetta Fini, Sabrina Giometto, Claudia Bartolini, Olga Paoletti, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Corrado Blandizzi, Marco Tuccori, Ersilia Lucenteforte
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Maria Antonietta Barbieri, Natasha Irrera, Irma Convertino
Drug Safety and Relevant Issues in the Real-World. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Marco Tuccori
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence. Expert opinion on drug discovery (2023)
Maria Antonietta Barbieri, Natasha Irrera, Irma Convertino
Drug Safety and Relevant Issues in the Real-World. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Irma Convertino, Valentina Lorenzoni, Rosa Gini, Giuseppe Turchetti, Elisabetta Fini, Sabrina Giometto, Claudia Bartolini, Olga Paoletti, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Corrado Blandizzi, Marco Tuccori, Ersilia Lucenteforte
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Sara Ferraro, Irma Convertino, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Marco Tuccori
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option. Expert opinion on drug discovery (2023)
Irma Convertino, Valentina Lorenzoni, Rosa Gini, Giuseppe Turchetti, Elisabetta Fini, Sabrina Giometto, Claudia Bartolini, Olga Paoletti, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Corrado Blandizzi, Marco Tuccori, Ersilia Lucenteforte
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Marco Tuccori
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence. Expert opinion on drug discovery (2023)
Marco Tuccori, Irma Convertino, Sara Ferraro, Emiliano Cappello, Giulia Valdiserra, Giulia de Luca, Massimo Franchini, Daniele Focosi
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall. Expert opinion on drug discovery 17 (6) (2022)
Irma Convertino, Sabrina Giometto, Rosa Gini, Massimiliano Cazzato, Marco Fornili, Giulia Valdiserra, Emiliano Cappello, Sara Ferraro, Claudia Bartolini, Olga Paoletti, Silvia Tillati, Laura Baglietto, Giuseppe Turchetti, Leopoldo Trieste, Valentina Lorenzoni, Corrado Blandizzi, Marta Mosca, Marco Tuccori, Ersilia Lucenteforte
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study. Journal of clinical medicine 10 (24) (2021)
Sara Ferraro, Marco Tuccori, Irma Convertino, Giulia Valdiserra, Emiliano Cappello, Fabrizio Maggi, Corrado Blandizzi, Daniele Focosi
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs. British journal of clinical pharmacology 87 (5) (2020)

Irma Convertino.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Irma Convertino